Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-09
1996-08-13
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548540, C07D207416, A61K 3140
Patent
active
055456570
ABSTRACT:
Heterocyclic compounds of the general formula: ##STR1## wherein, Z represents methylene group or sulfur atom, R represents a general formula:
REFERENCES:
patent: 4226775 (1980-10-01), McEvoy et al.
patent: 4412128 (1990-03-01), Hennins
patent: 4857537 (1989-08-01), Toda et al.
patent: 4880827 (1989-11-01), Tamoto
patent: 4912128 (1990-03-01), Henning et al.
patent: 4956380 (1990-09-01), Toda et al.
patent: 4983523 (1991-01-01), Henning et al.
patent: 4983624 (1991-01-01), Toda et al.
patent: 5051444 (1991-09-01), Tamoto et al.
patent: 5102877 (1992-04-01), Murate
Protein Nucleic Acid & Enzyme 26(6), p. 513-523 (1980) with concise explanation.
Nippon Nogeikagaku Kaisha 58(11), p. 1147-1153 (1984) with concise explanation.
American Cyanamid Company (AT-E-255) pp. 2-3.
Europe 286927 A (Abstract).
Europe 320753 A (Abstract).
Journal of Neurochemistry, 41(1), p. 69-75 (1983).
Journal of Neurochemistry, 42(1), p. 237-241 (1984).
Science, 211(4482), p. 601-603 (1981).
J. Biochemistry, 94, p. 1179-1190 (1983).
Methods in Enzyme, M. Charton, p. 323, 330-333 (1985).
Annual Report Medical Chemistry, Sinkula, vol. 10, p. 306, 310, 314 (1975).
Heterocycles, Chemical Abstract 236699p vol. 107, 1987 p. 789.
Green, Protective Groups in Organic Synthesis, pp. 249-265 (1981).
Ohno Hiroyuki
Ohuchida Shuichi
Toda Masaaki
Gerstl Robert
Ono Pharmaceutical Co. Ltd.
LandOfFree
Heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048167